Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Equity (2016 - 2025)

Standard Biotools (LAB) has disclosed Return on Equity for 15 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 4.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, up 4.0% year-over-year, with the annual reading at 0.04% for FY2025, 26.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.1% at Standard Biotools, up from 0.13% in the prior quarter.
  • The five-year high for Return on Equity was 20.04% in Q2 2022, with the low at 1.84% in Q1 2022.
  • Average Return on Equity over 5 years is 1.21%, with a median of 0.12% recorded in 2024.
  • The sharpest move saw Return on Equity soared 2055bps in 2022, then tumbled -1924bps in 2023.
  • Over 5 years, Return on Equity stood at 0.51% in 2021, then skyrocketed by 613bps to 2.64% in 2022, then tumbled by -89bps to 0.29% in 2023, then tumbled by -145bps to 0.13% in 2024, then grew by 29bps to 0.1% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.1%, 0.13%, and 0.12% for Q4 2025, Q3 2025, and Q2 2025 respectively.